We are live on ! Find out more
CAG

Crestwood Advisors Group Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.44%
This Fund
S&P 500
This Quarter Est. Return
+5.4%
1 Year Est. Return
+18.44%
3 Year Est. Return
+65.91%
5 Year Est. Return
+80.01%
10 Year Est. Return
+299.27%
AUM
$1.26B
AUM Growth
+$91.4M
Cap. Flow
+$33.2M
Cap. Flow %
2.64%
Top 10 Hldgs %
34.04%
Holding
203
New
36
Increased
76
Reduced
49
Closed
12

Top Sells

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$9.53M
2
FNF icon
Fidelity National Financial
FNF
+$6.63M
3
CVS icon
CVS Health
CVS
+$2.91M
4
SKT icon
Tanger
SKT
+$2.04M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.65M

Sector Composition

Rank Sector Weight
1 Financials 18.95%
2 Technology 13.97%
3 Healthcare 10.19%
4 Industrials 6.59%
5 Consumer Staples 5.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRGP icon
176
Targa Resources
TRGP
$60.4B
$201K 0.02%
+4,141
New +$185K
SNNA
177
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$200K 0.02%
+11,000
New +$233K
GAB icon
178
Gabelli Equity Trust
GAB
$1.74B
$186K 0.01%
30,681
-245
-0.8% -$1.49K
BRKL
179
DELISTED
Brookline Bancorp
BRKL
$180K 0.01%
11,494
+1
+0% +$16
BDJ icon
180
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.7B
$170K 0.01%
18,440
NFJ
181
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.41B
$149K 0.01%
11,407
NEA icon
182
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.36B
$148K 0.01%
10,800
AGEN
183
Agenus
AGEN
$249M
$107K 0.01%
1,678
GUT
184
Gabelli Utility Trust
GUT
$576M
$106K 0.01%
+15,390
New +$106K
IOVA icon
185
Iovance Biotherapeutics
IOVA
$2.23B
$100K 0.01%
12,500
RCG
186
RENN Fund
RCG
$20.7M
$100K 0.01%
100,000
DAKT icon
187
Daktronics
DAKT
$941M
$41K ﹤0.01%
40,989
HOLX
188
DELISTED
Hologic
HOLX
$33K ﹤0.01%
32,504
CATX icon
189
Perspective Therapeutics
CATX
$332M
$22K ﹤0.01%
5,482
PTN
190
Palatin Technologies
PTN
$13.7M
$21K ﹤0.01%
20
BNY
191
Bank of New York Mellon
BNY
$108B
-4,000
Closed -$212K
DVN icon
192
CALL
Devon Energy
DVN
$51.9B
-28,000
Closed -$1.03M
DVN icon
193
Devon Energy
DVN
$51.9B
-1,300
Closed -$48K
EOG icon
194
CALL
EOG Resources
EOG
$78B
-8,000
Closed -$774K
EPD icon
195
Enterprise Products Partners
EPD
$83.8B
-8,217
Closed -$214K
GILD icon
196
Gilead Sciences
GILD
$161B
-2,735
Closed -$222K
HYG icon
197
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
-2,954
Closed -$262K
HYMB icon
198
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.07B
-35,000
Closed -$999K
LFCR icon
199
Lifecore Biomedical
LFCR
$162M
-15,588
Closed -$202K
SPSB icon
200
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
-9,025
Closed -$277K

Similar funds

Crestwood Advisors Group's Q4 2017 Portfolio in Review

As of Q4 2017, Crestwood Advisors Group held 203 positions worth $1.26B, up 7.8% from $1.17B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Crestwood Advisors Group's Q4 2017 filing shows 36 new, 76 increased, 49 reduced and 12 closed positions. Its largest new stake was Black Knight, Inc. Common Stock: 278,230 shares worth $12.3M. The largest sale was SLB Ltd, an estimated $9.53M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.

  • Crestwood Advisors Group's largest Q4 2017 buy was Black Knight, Inc. Common Stock: 278,230 shares worth $12.3M.
  • Crestwood Advisors Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $18.5M increase.
  • Crestwood Advisors Group's biggest Q4 2017 reduction was SLB Ltd, cutting an estimated $9.53M.
  • Crestwood Advisors Group fully exited State Street SPDR Nuveen ICE High Yield Municipal Bond ETF in Q4 2017, selling an estimated $999K.
  • Crestwood Advisors Group's ten largest holdings make up 34% of its $1.26B portfolio in Q4 2017.
  • Crestwood Advisors Group opened 36 new positions and closed 12 in Q4 2017.
  • Crestwood Advisors Group's portfolio value rose 7.8% quarter-over-quarter to $1.26B.

Based on Crestwood Advisors Group's 13F filing for Q4 2017, filed 11 Jan 2018.